Tobacco Products
FDA’s Center for Tobacco Products (CTP) works to ensure a healthier life for every family.
Latest Updates from the Center for Tobacco Products
2020 National Youth Tobacco Survey
Latest data shows encouraging decline in overall youth tobacco product use.
FDA Authorizes IQOS 3 System Holder & Charger
Agency's review of supplemental PMTA finds that the minor design changes do not raise new concerns related to health effects or changes in use behavior.
Draft Guidance: Tobacco Perception & Intention Studies
FDA issues recommendations for designing and conducting TPPI studies that may help show that a tobacco product meets applicable marketing criteria.
September 9, 2020 Premarket Review Submission Deadline
FDA created a new webpage to provide manufacturers and importers with a single location for information and resources related to tobacco product applications for deemed new tobacco products, which were due by September 9, 2020. For tips, resources, and the latest information specific to these applications, visit the new webpage.
Learn MoreTobacco 21
In December 2019, the President signed legislation raising the federal minimum age for sale of tobacco products from 18 to 21 years. Effective immediately, this law makes it illegal for a retailer to sell any tobacco product—including cigarettes, cigars, and e-cigarettes—to anyone under 21. FDA has developed a webpage to provide the latest information on this new legislation—commonly referred to as “Tobacco 21” or “T21.” The webpage currently houses responses to commonly asked questions, a recently released webinar, CTP’s web statement on the new legislation, as well as information on resources for retailers to help verify the age of customers.
Learn MoreContact CTP
1-877-287-1373 (9am - 4pm ET)
For General Inquiries: AskCTP@fda.hhs.gov
Center for Tobacco Products
Food and Drug Administration
10903 New Hampshire Avenue
Document Control Center
Building 71, Room G335
Silver Spring, MD 20993-0002